Immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare and potentially
lethal disease characterized by fragmentary hemolysis, moderate-to-severe …

Recently, we showed that ADAMTS13 circulates in an open conformation during the acute
phase of immune-mediated thrombotic thrombocytopenic purpura (iTTP). Although the …

Thrombotic thrombocytopenic purpura (TTP) is a rare, relapsing, and life-threatening
disorder with an annual incidence of 10 cases per million people. TTP is a thrombotic …

Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis Guidelines
on the laboratory aspects of assays used in haemostasis and thrombosis Br J Haematol. 2020 …

Background Acquired or immune-mediated TTP (iTTP) is a life-threatening thrombotic
microangiopathy, characterized by the presence of microangiopathic hemolytic anemia and …

Атипичный гемолитико-уремический синдром (аГУС)-хроническое системное
заболевание генетической природы, в основе которого лежит неконтролируемая …

Introduction: Systemic lupus erythematosus (SLE)-related thrombocytopenia during
pregnancy and the postpartum period have been associated with adverse pregnancy …

Chronic thromboembolic pulmonary hypertension (CTEPH) is an important and severe
consequence of pulmonary embolism (PE), resulting from failure of thrombus resolution …

Atypical hemolytic-uremic syndrome (aHUS) is a chronic systemic disease of a genetic
nature, which is based on uncontrolled activation of the alternative complement pathway …

Thrombotic thrombocytopenic purpura (TTP) is a life-threatening, microvascular blood
disorder that affects approximately 5 people per million per year. The disorder is …